Prolonged neuromuscular block due to cholinesterase depletion by plasmapheresis

Journal of Clinical Anesthesia

Volumn 14, Issue 5, 2002, Pages 381-384

  Naik, Bhiken ^a   Hirshhorn, Steven ^a   Dharnidharka, Vikas R ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Cholinesterase; Glomerulosclerosis, focal segmental; Mivacurium; Neuromuscular blockade; Plasmapheresis; Pseudocholinesterase; Succinylcholine

Indexed keywords

ALBUMIN; ATRACURIUM; CHOLINESTERASE; CREATINE; FENTANYL; ISOFLURANE; MIVACURIUM; NITROUS OXIDE; SUXAMETHONIUM; THIOPENTAL;

ADULT; CASE REPORT; CHOLINESTERASE BLOOD LEVEL; COLORIMETRY; CONFERENCE PAPER; CONSERVATIVE TREATMENT; CONVALESCENCE; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; GENERAL ANESTHESIA; GLOMERULOSCLEROSIS; GRAFT REJECTION; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; NEUROMUSCULAR BLOCKING; NEUROMUSCULAR DISEASE; PLASMAPHERESIS; PRIORITY JOURNAL; PROTEIN DEPLETION; RECURRENT DISEASE;

ADULT; CHOLINESTERASES; FEMALE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; GRAFT REJECTION; HUMANS; ISOQUINOLINES; KIDNEY TRANSPLANTATION; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR DEPOLARIZING AGENTS; PLASMAPHERESIS; SKIN TRANSPLANTATION; SUCCINYLCHOLINE; TIME FACTORS; TRANSPLANTS;

EID: 0036696955     PISSN: 09528180     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-8180(02)00382-3     Document Type: Conference Paper

References (33)

1. Savarese J.J., Caldwell J.E., Lien C.A., Miller R.D. Pharmacology of muscle relaxants and their antagonists. Miller R.D. Anesthesia. 5th ed. 2000;412-490 Churchill Livingstone Philadelphia.
2. Kalow W., Genest K. A method for the detection of atypical forms of human serum cholinesterase. Determination of dibucaine numbers. Can J Biochem. 35:1957;339.
3. Viby-Môgensen J. Correlation of succinylcholine duration of action with plasma cholinesterase activity in subjects with the genotypically normal enzyme. Anesthesiology. 53:1980;517-520.
4. Shearer E.S., Russell G.N. The effect of cardiopulmonary bypass on cholinesterase activity. Anaesthesia. 48:1993;293-296.
5. Shipton E.A. Caesarean section in a patient with low serum cholinesterase activity following plasmapheresis. A case report and review. S Afr Med J. 64:1983;1068-1070.
6. Jackson S.H., Bailey G.W., Stevens G. Reduced plasma cholinesterase following haemodilutional cardiopulmonary bypass. Anaesthesia. 37:1982;319-321.
7. Bambauer R., Jutzler G.A., Albrecht D., Keller H.E., Kohler M. Indications of plasmapheresis and selection of different substitution solutions. Biomater Artif Cells Artif Organs. 17:1989;9-26.
8. Salmela K.T., von Willebrand E.O., Kyllonen L.E., et al. Acute vascular rejection in renal transplantation-diagnosis and outcome. Transplantation. 54:1992;858-862.
9. Aichberger C., Nussbaumer W., Rosmanith P., et al. Plasmapheresis for the treatment of acute vascular rejection in renal transplantation. Transplant Proc. 29:1997;169-170.
10. Greenstein S.M., Delrio M., Ong E., et al. Plasmapheresis treatment for recurrent focal sclerosis in pediatric renal allografts. Pediatr Nephrol. 14:2000;1061-1065.
11. Matalon A., Markowitz G.S., Joseph R.E., et al. Plasmapheresis treatment of recurrent FSGS in adult renal transplant recipients. Clin Nephrol. 56:2001;271-278.
12. Ohta T., Kawaguchi H., Hattori M., et al. Effect of pre- and postoperative plasmapheresis on posttransplant recurrence of focal segmental glomerulosclerosis in children. Transplantation. 71:2001;628-633.
13. Zimmerman S.W. Plasmapheresis and dipyridamole for recurrent focal glomerular sclerosis. Nephron. 40:1985;241-245.
14. Wood G.J., Hall G.M. Plasmapheresis and plasma cholinesterase. Br J Anaesth. 50:1978;945-949.
15. Wood G.J. Plasmapheresis and plasma-cholinesterase. Lancet. 1:1977;1305-1306.
16. Collard C.D., Baker B.W. 3rd, Johnson D., Bressler R., Harati Y. Cumulative reduction in serum cholinesterase following repeated therapeutic plasma exchange. J Clin Anesth. 8:1996;44-48.
17. Koprowicz K., Ooi D.S. A cautionary note regarding the effect of plasmapheresis on plasma cholinesterase. Clin Biochem. 30:1997;641-642.
18. Sirotzky L., Lewis E.J. Anesthesia related muscle paralysis in renal failure. Clin Nephrol. 10:1978;38-42.
19. Blobner M., Jelen-Esselborn S., Schneider G., et al. Effect of renal function on neuromuscular block induced by continuous infusion of mivacurium. Br J Anaesth. 74:1995;452-454.
20. Ryan D.W. Preoperative serum cholinesterase concentration in chronic renal failure. Clinical experience of suxamethonium in 81 patients undergoing renal transplant. Br J Anaesth. 49:1977;945-949.
21. Ichikawa I., Fogo A. Focal segmental glomerulosclerosis. Pediatr Nephrol. 10:1996;374-391.
22. Fogo A.B. Minimal change disease and focal segmental glomerulosclerosis. Nephrol Dial Transplant. 16:Suppl 6 2001;74-76.
23. Bolton W.K., Abdel-Rahman E. Pathogenesis of focal glomerulosclerosis. Nephron. 88:2001;6-13.
24. Ketteler M., Noble N.A., Border W.A. Transforming growth factor-beta and angiotensin II: the missing link from glomerular hyperfiltration to glomerulosclerosis? Annu Rev Physiol. 57:1995;279-295.
25. Tanaka R., Sugihara K., Tatematsu A., Fogo A. Internephron heterogeneity of growth factors and sclerosis-modulation of platelet-derived growth factor by angiotensin II. Kidney Int. 47:1995;131-139.
26. Cheong H.I., Han H.W., Park H.W., et al. Early recurrent nephrotic syndrome after renal transplantation in children with focal segmental glomerulosclerosis. Nephrol Dial Transplant. 15:2000;78-81.
27. Tejani A., Stablein D.H. Recurrence of focal segmental glomerulosclerosis posttransplantation: a special report of the North American Pediatric Renal Transplant Cooperative Study. J Am Soc Nephrol. 2:12 Suppl 1992;S258-S263.
28. Savin V.J., Sharma R., Sharma M., et al. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med. 334:1996;878-883.
29. Feld S.M., Figueroa P., Savin V., et al. Plasmapheresis in the treatment of steroid-resistant focal segmental glomerulosclerosis in native kidneys. Am J Kidney Dis. 32:1998;230-237.
30. Franke D., Zimmering M., Wolfish N., Ehrich J.H., Filler G. Treatment of FSGS with plasma exchange and immunadsorption. Pediatr Nephrol. 14:2000;965-969.
31. Ginsburg D.S., Dau P. Plasmapheresis in the treatment of steroid-resistant focal segmental glomerulosclerosis. Clin Nephrol. 48:1997;282-287.
32. Mitwalli A.H. Adding plasmapheresis to corticosteroids and alkylating agents: does it benefit patients with focal segmental glomerulosclerosis? Nephrol Dial Transplant. 13:1998;1524-1528.
33. Vecsei A.K., Muller T., Schratzberger E.C., et al. Plasmapheresis-induced remission in otherwise therapy-resistant FSGS. Pediatr Nephrol. 16:2001;898-900.